• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

PMV Pharma(PMVP.US)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
PMV Pharma released FY2025 9 Months earnings on November 12, 2025 (EST), actual revenue: USD 0, actual EPS: USD -1.1408
04:00
PMV Pharma released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3973 (forecast USD -0.4025)
04:00
Nov12
TD Cowen Maintains Buy Rating on PMV Pharmaceuticals Stock
16:07
Oct27
OrbiMed Advisors LLC Reports Sale of PMV Pharmaceuticals Inc. Common Stock
21:20
Aug8
PMV Pharma released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4077 (forecast USD -0.385)
03:00
PMV Pharma released FY2025 Semi-Annual earnings on August 7 (EST), actual revenue USD 0, actual EPS USD -0.7434
03:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -21.06 M, EPS -0.3973

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -21.21 M, EPS -0.4077

May9
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -17.44 M, EPS -0.3356

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
8.270
+101.71%
+4.164
ESHA
25.830
+79.62%
+11.240
NCL
0.3173
+63.56%
+0.124
ANGH
3.638
+56.81%
+1.318
VNDA
9.327
+32.68%
+2.296
DVLT
0.6813
+31.91%
+0.165
ORIS
1.608
+31.84%
+0.388
RDACR
0.2500
+31.58%
+0.060
AFJK
108.105
+30.91%
+25.525
ULY
3.590
+30.07%
+0.835
View More